Glyphosate, the compound used in the herbicide Roundup manufactured by US agrochemical corporation Monsanto, which earlier this month was acquired by German pharmaceuticals and chemicals giant Bayer, is suspected by several scientific studies of being carcinogenic, and notably of causing non-Hodgkin lymphoma. But now a French couple have launched a lawsuit against the firm over serious malformations of their son’s digestive and respiratory systems which they argue was caused by his mother’s exposure to glyphosate in the early weeks of pregnancy. Crucially, they say that Monsanto knew of the compound’s potential dangers, but failed to warn of them in product labelling. Dorothée Moisan reports.
French government statement came after National Assembly rejected moves to impose deadline for phasing out the herbicide.
The European Union on Monday gave the go-ahead to extend the licence for sales of the herbicide glyphosate, recognised by the World Health Organisation as “probably carcinogenic to humans”, for a further five years. The French government, which voted against move, has decided to unilaterally limit the licence to market glyphosate to three years. But France remains Europe’s biggest user, by volume, of agrochemicals, including many considered by scientific studies to present a health risk. Mediapart, in partnership with online journal Mediacités, details here, region by region and with interactive charts, their sales in France by volume, which in turn provides an indication of where they are most employed.
Glyphosate, the active ingredient in Monsanto's Roundup weedkiller, has stirred fierce debate since a WHO body said it was probably carcinogenic.
Monsanto product will be barred from self-service shopping outlets amid evidence that one of its constituents, glyphosate, is carcinogenic.